SlideShare a Scribd company logo
1 of 1
Download to read offline
Dosimetric improvements in a cohort of patients with simulated tracheal tumors receiving intensity
modulated radiotherapy (IMRT) accounting for optimization convergence errors (OCEs)
Todd J. Scarbrough, M.D.*
; Samuel R. Faught, M.D.*
; Charles R. Thomas, Jr., M.D.†*
OMHSMitchellMemorialCancerCenter,Dept.ofRadiationOncology,Owensboro,Kentucky,USA
†
OregonHealth&ScienceUniversity,Dept.ofRadiationMedicine,Portland,Oregon,USA
OMHS Mitchell Memorial Cancer Center
1020 Breckenridge Street, Owensboro, Kentucky 42303 USA
email: scarbrtj@gmail.com
phone: 1 270-231-6269
BACKGROUND
In many commercially available treatment planning systems
(TPSs), when planning IMRT, the fluence optimization process
uses a different algorithm than the actual dose calculation work-
space. In the Eclipse™ treatment planning system (v8.9.09.18617,
Varian Medical Systems, Palo Alto, CA, USA), for static field IMRT,
the fluence optimization algorithm used is dose volume opti-
mizer (DVO) v8.9.08. Of the calculation algorithms available in
Eclipse, there is evidence that the analytical anisotropic algo-
rithm (AAA v8.9.08) is significantly more accurate in predicting
delivered dose in most clinical situations, especially air/tissue in-
terface scenarios as encountered in lung or tracheal carcinoma
cases. However, the discrepancy in the DVO and AAA calcula-
tion algorithms induces optimization convergence errors (OCEs)
whichareespeciallynoticeableintheTPSintheseparticularclini-
calsituations:dosesbecomesignificantlyinhomogenouswithin
targets such that plans must be normalized to very low isodose
lines in turn inducing unwanted high target inhomogeneities
and/or hot spots in the plan. Zacarias and Mills (J Appl Clin Med
Phys, 10:3061, 2009) have devised a fluence summing method to
correct for OCEs in the Eclipse™ TPS by forcing the DVO to look
at calculated AAA results. We selected a non-random cohort of
10patientsfromourinstitutionforthistreatmentplanningstudy
and created, within the TPS, simulated tissue masses (using the
assign CT number function to voxels in the Eclipse™ TPS) within
the mid-trachea 3 cm in longitudinal dimension and having AP
and lateral dimensions equal to half the diameter of the trachea.
We then performed IMRT plans on these simulated masses with
or without OCE corrections, and recorded the results.
METHODS
ThemasseswerecreatedasaboveandconstitutedtheCTVwith-
in the simulated plans on 10 patients who had previously been
scannedandtreatedinthedepartmentforthoracicmalignancies
(andweredeceased);thesepatientspreviousscansservedasthe
planning phantoms for this study. A 5 mm isotropic margin was
added to the CTVs to create PTVs within the plans. The median
CTV volume was 4.5 ccs; PTV volume, 17.8 ccs. A nine-field equal-
lyspacedcoplanarstaticfieldbeamarrangementwasemployed
using dMLCs, 600MU/min dose rate. The PTV was optimized to
receive 100% of the Rx dose (60 Gy/30 fx). The maximum plan in-
homogeneity at optimization was set to be 62 Gy. A smoothing
factor of 20/20 X/Y was used for optimization. No other optimi-
zationparameterswereutilized.Eclipse™ DVOv8.9.08wasused
foroptimization.Afterinitialoptimization,planswerecalculated
using Eclipse™ AAA v8.9.08 (Plan 1). All plans were normalized
such that 95% of the PTV received 100% of the Rx dose or more.
PTVminimum,medianandmaximumdoseswererecorded,and
PTV conformity indices (CIs) calculated. Next, each Plan 1 was
re-optimized and re-calculated (again using AAA) to correct for
OCEs using the method and tools of Zacarias and Mills (Plan 2).
A smoothing factor of 0/0 X/Y was used for OCE-corrected opti-
mization.PTVminimum,medianandmaximumdoses,andPTV
CIs, were recorded for each Plan 2. Plan metrics were compared
using the Mann-Whitney test.
RESULTS
Plan 1 non-OCE and Plan 2 OCE-corrected plans differed signifi-
cantly. PTV minimum dose differed for Plan 1 vs 2 (median 56.5
Gy vs 58.3 Gy, p=0.0004). PTV median dose differed for Plan 1 vs
2 (median 62.6 Gy vs 60.7 Gy, p=0.0002). PTV maximum dose dif-
feredforPlan1vs2(67.4Gyvs62.2Gy,p=0.0002).TheCIdiffered
for Plan 1 vs 2 (median 1.77 vs 1.67, p=0.0002). Plan 1 calculations
revealedsignificantlymoretargetinhomogeneity(median112%)
than Plan 2 calculations (median 104%), normalizing 95% of the
PTV volumes to receive 60 Gy Rx dose or more.
CONCLUSIONS
Correcting for OCEs in this simulated group of patients with in-
traluminal tracheal tumors resulted in significantly more confor-
mal and homogenous plans.
contour as usual:
normal structures,
CTVs, PTVs, etc.
initial optimization:
PLAN_base
Re-optimize using
PLAN_base as a base dose
plan:
PLAN_dosecorr
sum plans:
1)convertfluencesto.txtfiles
dcm2Ascii.exe(onC:drive)
2)sumfluencesinMicrosoftExcel
http://tinyurl.com/imrt-oce
3)importnewsummedfluencesinto
eachnewfield
PLAN_final
Normalize as usual; if final
plan is unacceptable,
repeat re-optimization
contour as usual:
normal structures,
CTVs, PTVs, etc.
initial optimization:
PLAN_base
Re-optimize using
PLAN_base as a base dose
plan:
PLAN_dosecorr
sum plans:
1)convertfluencesto.txtfiles
dcm2Ascii.exe(onC:drive)
2)sumfluencesinMicrosoftExcel
http://tinyurl.com/imrt-oce
3)importnewsummedfluencesinto
eachnewfield
PLAN_final
Normalize as usual; if final
plan is unacceptable,
repeat re-optimization
FIGURE 3. Correcting for OCEs. An initial plan is optimized & calculated in Eclipse. Next, a second plan using the initial plan as a
base dose plan is optimized and calculated. The two plans’ fluences are summed beam-by-beam using the simple software pro-
grams outlined above. The summed fluences are imported back into Eclipse, replacing the initial fluences from the initial plans.
This plan is calculated, and then normalized per the planner’s specifications. The resultant plan usually results in significantly bet-
ter homogeneity and overall PTV coverage.
FIGURE 2. Nine-field, coplanar, equispaced beam arrangement as used for all plans.
FIGURE 1. Simulated tracheal tumor (the clinical target volume, CTV) created to occupy ½ the tracheal
lumen, and an inferior-superior extent of 3 cm. The CTV was assigned zero Hounsfield units. A margin
of 5 mm was added to create the planning target volume (PTV), which was the optimization target.
FIGURE 4. Optimization parameters for “PLAN_base” as outlined in the METHODS section.
FIGURE 5. The fluence patterns for each plan, as created by the optimization algorithm,
are converted to numerical text format (and individual “.txt” files) by the dcm2ascii.exe
program. The .txt files are then loaded into a custom-designed Microsoft Excel macro
(http://tinyurl.com/imrt-oce); this yields new summed fluences which are then loaded
back into the Eclipse treatment planning software. For most situations, only a single
dose-correction plan is necessary to yield desired calculated plan results.
Plan inhomogeneity max: 62 Gy
PTV prescription: 60 Gy
ForPLAN_dosecorr,PLAN_baseis
selected as a base dose plan, and
0/0 smoothing is set, as well.
PLAN_base PLAN_final
The majority of the PTV is cov-
ered by ≥105% of the pre-
scribed dose due to opti-
mization convergence
errors generated by
the DVO algorithm.
The PTV has a maxi-
mum dose inhomo-
geneity of 11.7%.
This could be clini-
cally significant
depending on
PTV overlap into
critical structures.
For PLAN_final, only a small pro-
portion of the PTV volume is re-
ceiving ≥103.5% of the dose and
the maximum inhomogeneity in
the PTV is only 4.7%. Furthermore,
less monitor units will be used in
PLAN_final vs. PLAN_base, which re-
sults in slightly faster treatment times and
slightly less scatter dose to the patient.
FIGURE 6. Correcting for OCEs generates plans which result in significantly less target inhomogeneity and significantly better overall dose conformity.
Air/tissue interfaces
(or high density/low
density interfaces)
are regions in the
body where radia-
tion dose absorption
changes rapidly. The
anisotropic analytic al-
gorithm (AAA) models
this reasonably well, and
is a dose calculation al-
gorithm available in the
Eclipse treatment planning
system. However, the optimi-
zation algorithm for static field
IMRT (dose volume optimizer,
DVO) does not model this dose
phenomenon as well as AAA. Yet
AAA uses the fluences created by
the DVO.
We can “correct”
the relative DVO
error by running
second plans
using AAA cal-
culation of the
first plan as a
basedoseplan.
Then, we sum
the fluences of
each beam from
each plan togeth-
er, and re-calculate
thenewplanusingAAA.
“problem”
areas

More Related Content

Viewers also liked

Build your own reality
Build your own realityBuild your own reality
Build your own realityRob Manson
 
Techniquefor choirs
Techniquefor choirsTechniquefor choirs
Techniquefor choirsS Marley
 
Tipos de-trampas-de-petroleo Original
Tipos de-trampas-de-petroleo OriginalTipos de-trampas-de-petroleo Original
Tipos de-trampas-de-petroleo Originalmax
 
Ακροστιχίδες της φύσης
Ακροστιχίδες της φύσηςΑκροστιχίδες της φύσης
Ακροστιχίδες της φύσηςkougiou
 
Catalogue produits 2016
Catalogue produits 2016Catalogue produits 2016
Catalogue produits 2016wellandyou
 
Unified Payments Interface (UPI) - easy way to transfer money through banks
Unified Payments Interface (UPI) - easy way to transfer money through banksUnified Payments Interface (UPI) - easy way to transfer money through banks
Unified Payments Interface (UPI) - easy way to transfer money through banksCA Janardhana Gouda
 
Unified Payment Interface
Unified Payment InterfaceUnified Payment Interface
Unified Payment InterfaceAkash Chandra
 
Go cashless, India
Go cashless, IndiaGo cashless, India
Go cashless, IndiaRanjan Varma
 
Role of Radiation Therapy for Lung Cancer
Role of Radiation Therapy for Lung CancerRole of Radiation Therapy for Lung Cancer
Role of Radiation Therapy for Lung Cancerspa718
 
Technical Advances in radiotherapy for Lung (and liver) Cancer
Technical Advances in radiotherapy for Lung (and liver) CancerTechnical Advances in radiotherapy for Lung (and liver) Cancer
Technical Advances in radiotherapy for Lung (and liver) Cancerspa718
 

Viewers also liked (13)

Build your own reality
Build your own realityBuild your own reality
Build your own reality
 
Techniquefor choirs
Techniquefor choirsTechniquefor choirs
Techniquefor choirs
 
Issuu ppt
Issuu pptIssuu ppt
Issuu ppt
 
Tipos de-trampas-de-petroleo Original
Tipos de-trampas-de-petroleo OriginalTipos de-trampas-de-petroleo Original
Tipos de-trampas-de-petroleo Original
 
Ακροστιχίδες της φύσης
Ακροστιχίδες της φύσηςΑκροστιχίδες της φύσης
Ακροστιχίδες της φύσης
 
Web tools
Web toolsWeb tools
Web tools
 
Catalogue produits 2016
Catalogue produits 2016Catalogue produits 2016
Catalogue produits 2016
 
Unified Payments Interface (UPI) - easy way to transfer money through banks
Unified Payments Interface (UPI) - easy way to transfer money through banksUnified Payments Interface (UPI) - easy way to transfer money through banks
Unified Payments Interface (UPI) - easy way to transfer money through banks
 
Unified Payment Interface
Unified Payment InterfaceUnified Payment Interface
Unified Payment Interface
 
Go cashless, India
Go cashless, IndiaGo cashless, India
Go cashless, India
 
Demonetization
DemonetizationDemonetization
Demonetization
 
Role of Radiation Therapy for Lung Cancer
Role of Radiation Therapy for Lung CancerRole of Radiation Therapy for Lung Cancer
Role of Radiation Therapy for Lung Cancer
 
Technical Advances in radiotherapy for Lung (and liver) Cancer
Technical Advances in radiotherapy for Lung (and liver) CancerTechnical Advances in radiotherapy for Lung (and liver) Cancer
Technical Advances in radiotherapy for Lung (and liver) Cancer
 

Similar to poster3

Tomosurgery Presentation
Tomosurgery PresentationTomosurgery Presentation
Tomosurgery Presentationngowdar
 
Verification of a treatment planning system using an in-house designedtrunk p...
Verification of a treatment planning system using an in-house designedtrunk p...Verification of a treatment planning system using an in-house designedtrunk p...
Verification of a treatment planning system using an in-house designedtrunk p...IOSR Journals
 
EPID FOR MAGNA FIELD
EPID FOR MAGNA FIELDEPID FOR MAGNA FIELD
EPID FOR MAGNA FIELDKanhu Charan
 
IMRT by Musaib Mushtaq.ppt
IMRT by Musaib Mushtaq.pptIMRT by Musaib Mushtaq.ppt
IMRT by Musaib Mushtaq.pptMusaibMushtaq
 
Topic -Analysis of Patients specific Quality Assurance of IMRT/VMAT
Topic -Analysis of Patients specific Quality Assurance of IMRT/VMATTopic -Analysis of Patients specific Quality Assurance of IMRT/VMAT
Topic -Analysis of Patients specific Quality Assurance of IMRT/VMATRajeev Kumar Pandit
 
Overview Of Array Based Copy Number
Overview Of Array Based Copy NumberOverview Of Array Based Copy Number
Overview Of Array Based Copy NumberJosephseki28
 
Magna field irradiation
Magna field irradiationMagna field irradiation
Magna field irradiationSabari Kumar
 
Plan evaluation in Radiotherapy- Dr Kiran
Plan evaluation in Radiotherapy- Dr KiranPlan evaluation in Radiotherapy- Dr Kiran
Plan evaluation in Radiotherapy- Dr KiranKiran Ramakrishna
 
ICRU 83 report on dose prescription in IMRT
ICRU 83 report on dose prescription in IMRTICRU 83 report on dose prescription in IMRT
ICRU 83 report on dose prescription in IMRTAnagha pachat
 

Similar to poster3 (20)

IGRT APP.pdf
IGRT APP.pdfIGRT APP.pdf
IGRT APP.pdf
 
Tomosurgery Presentation
Tomosurgery PresentationTomosurgery Presentation
Tomosurgery Presentation
 
Verification of a treatment planning system using an in-house designedtrunk p...
Verification of a treatment planning system using an in-house designedtrunk p...Verification of a treatment planning system using an in-house designedtrunk p...
Verification of a treatment planning system using an in-house designedtrunk p...
 
jmrs156
jmrs156jmrs156
jmrs156
 
EPID FOR MAGNA FIELD
EPID FOR MAGNA FIELDEPID FOR MAGNA FIELD
EPID FOR MAGNA FIELD
 
F04433538
F04433538F04433538
F04433538
 
IMRT by Musaib Mushtaq.ppt
IMRT by Musaib Mushtaq.pptIMRT by Musaib Mushtaq.ppt
IMRT by Musaib Mushtaq.ppt
 
Inverse Planning
Inverse PlanningInverse Planning
Inverse Planning
 
JBUON-21-1-33
JBUON-21-1-33JBUON-21-1-33
JBUON-21-1-33
 
Imrt&vmat
Imrt&vmatImrt&vmat
Imrt&vmat
 
Topic -Analysis of Patients specific Quality Assurance of IMRT/VMAT
Topic -Analysis of Patients specific Quality Assurance of IMRT/VMATTopic -Analysis of Patients specific Quality Assurance of IMRT/VMAT
Topic -Analysis of Patients specific Quality Assurance of IMRT/VMAT
 
Overview Of Array Based Copy Number
Overview Of Array Based Copy NumberOverview Of Array Based Copy Number
Overview Of Array Based Copy Number
 
Magna field irradiation
Magna field irradiationMagna field irradiation
Magna field irradiation
 
tomotherapy
tomotherapytomotherapy
tomotherapy
 
tomotherapy
tomotherapytomotherapy
tomotherapy
 
Random and systematic errors 25.10.12
Random and systematic errors 25.10.12Random and systematic errors 25.10.12
Random and systematic errors 25.10.12
 
Icru 58.
Icru 58.Icru 58.
Icru 58.
 
I M R Tintro
I M R TintroI M R Tintro
I M R Tintro
 
Plan evaluation in Radiotherapy- Dr Kiran
Plan evaluation in Radiotherapy- Dr KiranPlan evaluation in Radiotherapy- Dr Kiran
Plan evaluation in Radiotherapy- Dr Kiran
 
ICRU 83 report on dose prescription in IMRT
ICRU 83 report on dose prescription in IMRTICRU 83 report on dose prescription in IMRT
ICRU 83 report on dose prescription in IMRT
 

More from Todd Scarbrough

“Alopecia-less” Whole Brain Radiotherapy: Preliminary Experience and Outcomes
“Alopecia-less” Whole Brain Radiotherapy: Preliminary Experience and Outcomes“Alopecia-less” Whole Brain Radiotherapy: Preliminary Experience and Outcomes
“Alopecia-less” Whole Brain Radiotherapy: Preliminary Experience and OutcomesTodd Scarbrough
 
SBRT/SABR for Early Stage Lung Cancer: A Brief Overview
SBRT/SABR for Early Stage Lung Cancer: A Brief OverviewSBRT/SABR for Early Stage Lung Cancer: A Brief Overview
SBRT/SABR for Early Stage Lung Cancer: A Brief OverviewTodd Scarbrough
 

More from Todd Scarbrough (8)

“Alopecia-less” Whole Brain Radiotherapy: Preliminary Experience and Outcomes
“Alopecia-less” Whole Brain Radiotherapy: Preliminary Experience and Outcomes“Alopecia-less” Whole Brain Radiotherapy: Preliminary Experience and Outcomes
“Alopecia-less” Whole Brain Radiotherapy: Preliminary Experience and Outcomes
 
Cancer prevention
Cancer preventionCancer prevention
Cancer prevention
 
Cancer screening
Cancer screeningCancer screening
Cancer screening
 
SBRTweb.nearmc
SBRTweb.nearmcSBRTweb.nearmc
SBRTweb.nearmc
 
ASTRO 07 PROS IGRT
ASTRO 07 PROS IGRTASTRO 07 PROS IGRT
ASTRO 07 PROS IGRT
 
MIMAfrench
MIMAfrenchMIMAfrench
MIMAfrench
 
Rea_W_Sum_2012
Rea_W_Sum_2012Rea_W_Sum_2012
Rea_W_Sum_2012
 
SBRT/SABR for Early Stage Lung Cancer: A Brief Overview
SBRT/SABR for Early Stage Lung Cancer: A Brief OverviewSBRT/SABR for Early Stage Lung Cancer: A Brief Overview
SBRT/SABR for Early Stage Lung Cancer: A Brief Overview
 

poster3

  • 1. Dosimetric improvements in a cohort of patients with simulated tracheal tumors receiving intensity modulated radiotherapy (IMRT) accounting for optimization convergence errors (OCEs) Todd J. Scarbrough, M.D.* ; Samuel R. Faught, M.D.* ; Charles R. Thomas, Jr., M.D.†* OMHSMitchellMemorialCancerCenter,Dept.ofRadiationOncology,Owensboro,Kentucky,USA † OregonHealth&ScienceUniversity,Dept.ofRadiationMedicine,Portland,Oregon,USA OMHS Mitchell Memorial Cancer Center 1020 Breckenridge Street, Owensboro, Kentucky 42303 USA email: scarbrtj@gmail.com phone: 1 270-231-6269 BACKGROUND In many commercially available treatment planning systems (TPSs), when planning IMRT, the fluence optimization process uses a different algorithm than the actual dose calculation work- space. In the Eclipse™ treatment planning system (v8.9.09.18617, Varian Medical Systems, Palo Alto, CA, USA), for static field IMRT, the fluence optimization algorithm used is dose volume opti- mizer (DVO) v8.9.08. Of the calculation algorithms available in Eclipse, there is evidence that the analytical anisotropic algo- rithm (AAA v8.9.08) is significantly more accurate in predicting delivered dose in most clinical situations, especially air/tissue in- terface scenarios as encountered in lung or tracheal carcinoma cases. However, the discrepancy in the DVO and AAA calcula- tion algorithms induces optimization convergence errors (OCEs) whichareespeciallynoticeableintheTPSintheseparticularclini- calsituations:dosesbecomesignificantlyinhomogenouswithin targets such that plans must be normalized to very low isodose lines in turn inducing unwanted high target inhomogeneities and/or hot spots in the plan. Zacarias and Mills (J Appl Clin Med Phys, 10:3061, 2009) have devised a fluence summing method to correct for OCEs in the Eclipse™ TPS by forcing the DVO to look at calculated AAA results. We selected a non-random cohort of 10patientsfromourinstitutionforthistreatmentplanningstudy and created, within the TPS, simulated tissue masses (using the assign CT number function to voxels in the Eclipse™ TPS) within the mid-trachea 3 cm in longitudinal dimension and having AP and lateral dimensions equal to half the diameter of the trachea. We then performed IMRT plans on these simulated masses with or without OCE corrections, and recorded the results. METHODS ThemasseswerecreatedasaboveandconstitutedtheCTVwith- in the simulated plans on 10 patients who had previously been scannedandtreatedinthedepartmentforthoracicmalignancies (andweredeceased);thesepatientspreviousscansservedasthe planning phantoms for this study. A 5 mm isotropic margin was added to the CTVs to create PTVs within the plans. The median CTV volume was 4.5 ccs; PTV volume, 17.8 ccs. A nine-field equal- lyspacedcoplanarstaticfieldbeamarrangementwasemployed using dMLCs, 600MU/min dose rate. The PTV was optimized to receive 100% of the Rx dose (60 Gy/30 fx). The maximum plan in- homogeneity at optimization was set to be 62 Gy. A smoothing factor of 20/20 X/Y was used for optimization. No other optimi- zationparameterswereutilized.Eclipse™ DVOv8.9.08wasused foroptimization.Afterinitialoptimization,planswerecalculated using Eclipse™ AAA v8.9.08 (Plan 1). All plans were normalized such that 95% of the PTV received 100% of the Rx dose or more. PTVminimum,medianandmaximumdoseswererecorded,and PTV conformity indices (CIs) calculated. Next, each Plan 1 was re-optimized and re-calculated (again using AAA) to correct for OCEs using the method and tools of Zacarias and Mills (Plan 2). A smoothing factor of 0/0 X/Y was used for OCE-corrected opti- mization.PTVminimum,medianandmaximumdoses,andPTV CIs, were recorded for each Plan 2. Plan metrics were compared using the Mann-Whitney test. RESULTS Plan 1 non-OCE and Plan 2 OCE-corrected plans differed signifi- cantly. PTV minimum dose differed for Plan 1 vs 2 (median 56.5 Gy vs 58.3 Gy, p=0.0004). PTV median dose differed for Plan 1 vs 2 (median 62.6 Gy vs 60.7 Gy, p=0.0002). PTV maximum dose dif- feredforPlan1vs2(67.4Gyvs62.2Gy,p=0.0002).TheCIdiffered for Plan 1 vs 2 (median 1.77 vs 1.67, p=0.0002). Plan 1 calculations revealedsignificantlymoretargetinhomogeneity(median112%) than Plan 2 calculations (median 104%), normalizing 95% of the PTV volumes to receive 60 Gy Rx dose or more. CONCLUSIONS Correcting for OCEs in this simulated group of patients with in- traluminal tracheal tumors resulted in significantly more confor- mal and homogenous plans. contour as usual: normal structures, CTVs, PTVs, etc. initial optimization: PLAN_base Re-optimize using PLAN_base as a base dose plan: PLAN_dosecorr sum plans: 1)convertfluencesto.txtfiles dcm2Ascii.exe(onC:drive) 2)sumfluencesinMicrosoftExcel http://tinyurl.com/imrt-oce 3)importnewsummedfluencesinto eachnewfield PLAN_final Normalize as usual; if final plan is unacceptable, repeat re-optimization contour as usual: normal structures, CTVs, PTVs, etc. initial optimization: PLAN_base Re-optimize using PLAN_base as a base dose plan: PLAN_dosecorr sum plans: 1)convertfluencesto.txtfiles dcm2Ascii.exe(onC:drive) 2)sumfluencesinMicrosoftExcel http://tinyurl.com/imrt-oce 3)importnewsummedfluencesinto eachnewfield PLAN_final Normalize as usual; if final plan is unacceptable, repeat re-optimization FIGURE 3. Correcting for OCEs. An initial plan is optimized & calculated in Eclipse. Next, a second plan using the initial plan as a base dose plan is optimized and calculated. The two plans’ fluences are summed beam-by-beam using the simple software pro- grams outlined above. The summed fluences are imported back into Eclipse, replacing the initial fluences from the initial plans. This plan is calculated, and then normalized per the planner’s specifications. The resultant plan usually results in significantly bet- ter homogeneity and overall PTV coverage. FIGURE 2. Nine-field, coplanar, equispaced beam arrangement as used for all plans. FIGURE 1. Simulated tracheal tumor (the clinical target volume, CTV) created to occupy ½ the tracheal lumen, and an inferior-superior extent of 3 cm. The CTV was assigned zero Hounsfield units. A margin of 5 mm was added to create the planning target volume (PTV), which was the optimization target. FIGURE 4. Optimization parameters for “PLAN_base” as outlined in the METHODS section. FIGURE 5. The fluence patterns for each plan, as created by the optimization algorithm, are converted to numerical text format (and individual “.txt” files) by the dcm2ascii.exe program. The .txt files are then loaded into a custom-designed Microsoft Excel macro (http://tinyurl.com/imrt-oce); this yields new summed fluences which are then loaded back into the Eclipse treatment planning software. For most situations, only a single dose-correction plan is necessary to yield desired calculated plan results. Plan inhomogeneity max: 62 Gy PTV prescription: 60 Gy ForPLAN_dosecorr,PLAN_baseis selected as a base dose plan, and 0/0 smoothing is set, as well. PLAN_base PLAN_final The majority of the PTV is cov- ered by ≥105% of the pre- scribed dose due to opti- mization convergence errors generated by the DVO algorithm. The PTV has a maxi- mum dose inhomo- geneity of 11.7%. This could be clini- cally significant depending on PTV overlap into critical structures. For PLAN_final, only a small pro- portion of the PTV volume is re- ceiving ≥103.5% of the dose and the maximum inhomogeneity in the PTV is only 4.7%. Furthermore, less monitor units will be used in PLAN_final vs. PLAN_base, which re- sults in slightly faster treatment times and slightly less scatter dose to the patient. FIGURE 6. Correcting for OCEs generates plans which result in significantly less target inhomogeneity and significantly better overall dose conformity. Air/tissue interfaces (or high density/low density interfaces) are regions in the body where radia- tion dose absorption changes rapidly. The anisotropic analytic al- gorithm (AAA) models this reasonably well, and is a dose calculation al- gorithm available in the Eclipse treatment planning system. However, the optimi- zation algorithm for static field IMRT (dose volume optimizer, DVO) does not model this dose phenomenon as well as AAA. Yet AAA uses the fluences created by the DVO. We can “correct” the relative DVO error by running second plans using AAA cal- culation of the first plan as a basedoseplan. Then, we sum the fluences of each beam from each plan togeth- er, and re-calculate thenewplanusingAAA. “problem” areas